Alvotech Issues New Shares to Holders of Convertible Bonds
Alvotech Issues New Shares to Holders of Convertible Bonds
REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued new shares to holders of subordinated convertible bonds, originally issued by Alvotech on November 16, 2022, and December 20, 2022, with maturity on December 20, 2025 (the "Convertible Bonds").
冰島雷克雅未克，2024年7月1日（環球新聞專線）——專門爲全球患者開發和製造生物仿製藥的全球生物技術公司Alvotech（納斯達克股票代碼：ALVO）今天向次級可轉換債券的持有人發行了新股，該債券最初由Alvotech於2022年11月16日和2022年12月20日發行，到期日爲2025年12月20日（“可轉換債券”）。
Today, Alvotech issued 22,073,578 new ordinary shares in exchange for Convertible Bonds, at the fixed price of US$10.00 per share. The majority of the holders of Convertible Bonds exercising their conversion right, are existing shareholders in Alvotech.
今天，Alvotech發行了22,073,578股新的普通股以換取可轉換債券，固定價格爲每股10.00美元。行使轉換權的可轉換債券的大多數持有人是Alvotech的現有股東。
Following the conversion of the Convertible Bonds into shares, the total number of issued shares in Alvotech is 324,801,040 and the total number of outstanding shares is 301,944,470. Pursuant to terms of the Convertible Bonds, the newly issued shares shall be delivered to their owners no later than seven business days from today.
將可轉換債券轉換爲股票後，Alvotech的已發行股票總數爲324,801,040股，已發行股票總數爲301,944,470股。根據可轉換債券的條款，新發行的股票應在今天起的七個工作日內交付給其所有者。